Disability and Quality of Life Measures in older frail and prefrail people with type 2 diabetes. The MIDFRAIL-Study
Primary result · Improvement in QOL (EQ-5D-5L)Result — go to the resultOdds ratio 1.75 95 % CI 1.20–2.54Authors' conclusion
IG has proven to be effective in increasing QOL and avoiding the worsening of QOL and basic ADL.
Study context
- Population
- Prefrail and frail individuals ≥ 70 years with T2D; mean age 77.83 years, 50.65 % men
- Participants
- 843 participants
- Comparison
- Multicomponent intervention vs usual care
Primary result
Improvement in QOL (EQ-5D-5L)
Odds ratio
1.75
95 % CI 1.20–2.54
p-value 0.004
IGvs UCG
OR 1.75 (95 % CI 1.20–2.54); p-value 0.004
As reported in the abstract
Further findings
| Outcome | OR (95 % CI) | P value | |
|---|---|---|---|
| Deterioration in Barthel Index (basic ADL)Lower probability of deterioration with IG | 0.59 (0.37–0.93) | 0.023 | |
| 0.20.5125Odds ratio (log scale) |
| Outcome | OR (95 % CI) | P value |
|---|---|---|
| Deterioration in QOLLower probability of deterioration with IG | 0.61 (0.87–0.54) | 0.006 |
Adherence needed for benefit
- Adherence needed for quality of life (QOL) benefits
- ≥93 %
- Adherence needed for Barthel Index benefits
- > 84.38 %
Original publication
Disability and Quality of Life Measures in older frail and prefrail people with type 2 diabetes. The MIDFRAIL-Study. Diabetes Res Clin Pract. Published 27 July 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →